Lexeo Therapeutics, Inc. (LXEO) stock
LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$3.23+0.36 (+12.54%)
Close on Nov 16, 2026Market cap $265.01MP/E –Yield –
Lexeo Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Lexeo Therapeutics's operating margin for the twelve months ending Dec 31, 2022 was -9252.1%. For fiscal 2022 it was -9252.1%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -9252.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2022 | Sep 30, 2022 | -3292.3% | – |
See a number that looks wrong?